PF-06463922 CAS NO.1454846-35-5

Searchingredient.com concentrates on building a global leading search engine for ingredients in food, feed and pharmaceutical industry, thanks to its strong backgrounds in food, beverage and pharmaceutical raw material business. Buyers may get precise quotations for almost any food and feed ingredients, active pharmaceutical ingredients and relevant chemical reagents within 24 hours online at zero cost, as searchingredient.com has developed close ties with more than 100,000 certified suppliers worldwide over the past years, and a reliable inquiry tracking team and system. Searchingredient.com product database covers more than 20,000 food ingredients, active pharmaceutical ingredients and relevant chemical reagents, forming a professional reference book and dictionary of the industry, its high-standard chemical information data ranging from CAS No., EC No., molecular formula, molecular weight, product description, product synonyms to molecular structure. In the meantime, searchingredient.com owns a professional editorial team with international perspective, which focuses on collection of all sorts of industry information and provides industry news, market development tracking, in-depth analysis report and business review for suppliers, manufacturers, traders and purchasing agents from the food, feed and active pharmaceutical ingredients industry worldwide.

PF-06463922 Usage And Synthesis Uses Anaplastic lymphoma kinase (ALK) is a receptor tyrosine kinase that promotes cell proliferation and blocks apoptosis. PF-06463922 is an ATP-competitive, selective inhibitor of ALK (Ki = < 0.07 nM) and c-Ros oncogene 1 (ROS1, Ki = 0.7 nM). It has strong activity against all known ALK and ROS1 mutants identified in patients, including the EML4-L1196M mutant of ALK (Ki = < 0.02 nM). PF-06463922 is orally available, displaying inhibition of ALK phosphorylation and antitumor efficacy in a xenograft model expressing EML4-L1196M ALK. It demonstrates efficient blood-brain barrier penetration, produces brain tumor regression in mice harboring EML4-ALK tumors, and increases overall survival.[Cayman Chemical]